DISCUSSIONS and DECISIONS Sophia, 22 nd May 2006 Public Health Program EUROPEAN COMMISSION: HEALTH & CONSUMER PROTECTION DIRECTORATE - GENERAL www.tumori.net/eurochip.

Slides:



Advertisements
Similar presentations
THE EUROPEAN GENERAL PRODUCT SAFETY NETWORK Erik Hansson DG Health and Consumer Protection European Commission.
Advertisements

Together. Free your energies How open and collaborative are public administrations in Europe? A benchmarking perspective October 2011.
EUROCHIP-3 WORK PACKAGES. MAIN WORK PACKAGES of EUROCHIP-3 Ahti Anttila Adherence to cervical screening in 5 Eastern EU countries Renée Otter Population-based.
EUROCHIP-3: WP-4 Publications Paolo Baili Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Indicators to be included in the final list for EC Eurochip-3 WP6 meeting Brussels, September 9, 2011.
EUROCHIP 3 WP1 and WP3 Meeting Feeding the project Evaluation 17 September 2010 Sofia, Bulgaria.
Dr Andrea Micheli Descriptive Epidemiology and Health Planning Unit Fondazione IRCCS “Istituto Nazionale dei Tumori” Milan Public Health Programme EUROPEAN.
FROM EUROCHIP-1 TO EUROCHIP-2 EUROCHIP-2 - The action Public Health Program EUROPEAN COMMISSION: HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL.
Secretariat General - Codecision Unit
1 THE POSSIBLE INFLUENCE OF THE MEDICAL STAFF INVOLVED IN THE ORGANIZED CERVICAL CANCER (CC) SCREENING OVER THE RESPONSIVENESS TO THE CENTRALLY ISSUED.
Public Health Programme EUROPEAN COMMISSION: HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL EUROCHIP-3 WP-4 Update EUROCHIP: EUROpean Cancer Health Indicator.
PILOT STUDIES Brighton, 15 th February 2006 Public Health Program EUROPEAN COMMISSION: HEALTH & CONSUMER PROTECTION DIRECTORATE - GENERAL
THE EUROCHIP PROJECTS Health Indicators for Health Indicators for Monitoring Cancer in Europe
Identification of critical success factors for implementing NLLS, through collaboration and exchange of expertise IDENTIFY LLP-2008-RO-KA1-KA1NLLS.
Cervical cancer screening in Estonia: present situation Piret Veerus Department of Epidemiology and Biostatistics National Institute for Health Development.
Cervical cancer screening problems and barriers in Latvia
1 Cervical Cancer Screening in Latvia: Present, Problems and Future Ilze Viberga, MD, PhD, Ob/Gyn.
EUROCHIP-2 European Public Health Action on Cervical Cancer Screening GRELL Palma de Majorca Public Health Program EUROPEAN COMMISSION: HEALTH &
1 PROPOSAL FOR PROCEDURES AND SCOPE OF SHA DATA COLLECTION UNDER THE CO-OPERATION BETWEEN OECD, EUROSTAT AND WHO 7 th Meeting of Health Accounts Experts.
Erik Hansson DG Health and Consumer Protection (DG SANCO) European Commission Developments on product safety in the EU.
1 EUROPA DONNA – The European Breast Cancer Coalition Susan Knox, Executive Director KEEPING BREAST CANCER ON THE EUROPEAN HEALTH AGENDA.
NOT ALL PAST SUCCESSES IN CANCER RESEARCH HAVE BEEN FOLLOWED BY ACTIONS EUROCHIP-2 THE ACTION Project & news EUROCHIP-2 THE ACTION Project & news Public.
DISCUSSION. EUROCHIP-2 ACTION PLAN COUNTRY 1COUNTRY 2COUNTRY 3 COUNTRY 30 ACTION1ACTION1 ACTION2ACTION2 ACTION3ACTION3 ACTION3ACTION3 ACTION4ACTION4 ACTION4ACTION4.
1 Cervical cancer screening in Lithuania 2005 Maiori, Italy Juozas Kurtinaitis Institute of Oncology, Vilnius University
EUROCHIP-2 ACTIVITY ON CERVICAL CANCER SCREENING BULGARIA.
1 "Cancer and the European Citizen – it’s time to deliver! Francesco De Lorenzo ECPC President ECPC Members in Action Conference 2009 ALL CANCER PATIENTS.
Grants LXIV International Council Meeting 19th – 26th October, Bodrum Turkey.
Working together with EFSA in making Europe’s food safe Warszawa, 16. April 2013 Cooperation between EFSA and Member States Jacek Postupolski National.
EUROCHIP-2 EUROCHIP-2 - The Action Public Health Program EUROPEAN COMMISSION: HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL.
Cervical cancer screening: problems and barriers in Estonia Piret Veerus Department of Epidemiology and Biostatistics National Institute for Health Development.
Cervical cancer screening problems and barriers in Lithuania Presented by Ruta Kurtinaitiene Tallin April 2, 2007.
European Union against cancer The EUROCHIP project 1st International Cancer Control Congress Vancouver, October 2005 Public Health Program EUROPEAN.
EUROCHIP-2 results in Lithuania Varenna October 18, 2007 Presented by Ruta Kurtinaitiene
Chapter 8.  The attitudes held by a significant number of people on matters of government and politics.
2008LIFE presentation LIFE+ call for proposals.
Government – Civil Society Interaction Montenegro Country Case Network for Affirmation of NGO Sector – MANS, October 2002.
EUROCHIP-Italia in EUROCHIP-2 Health Indicators for Monitoring Cancer in Europe Public Health Program EUROPEAN COMMISSION: HEALTH & CONSUMER PROTECTION.
Dr Andrea Micheli Descriptive Epidemiology and Health Planning Unit Fondazione IRCCS “Istituto Nazionale dei Tumori” Milan Public Health Programme EUROPEAN.
Successful experiences for the availability and use of referral guidelines. Denis Remedios Clinical Radiologist, Northwick Park Hospital London, UK.
DESCRIPTION OF THE MONITORING AND EVALUATION SYSTEM IN POLAND Action Plan and the Two-year NRN Operational Plans.
EUNetPaS is a project supported by a grant from the EAHC. The sole responsibility for the content of this presentation lies with the author(s). The EAHC.
Performance Management at local level - a Council of Europe perspective of Good Governance COUNCIL OF EUROPE Directorate General of Democracy and Political.
D R I V I N G F O R R E S U L T S : S T R E N G T H E N I N G T H E S C I E N C E B A S I S A N D C A T A L Y T I C R O L E O F U N E P UNECE Working Group.
The United Nations/Royal Thai Government (UN/RTG) joint team on social protection LONG TEM CARE POLICY FOR ELDERLY IN THAILAND.
1 Brussels 16 January What is HOPE? HOPE is an excellent example of the diversity of European healthcare system What is HOPE? HOPE is an excellent.
M O N T E N E G R O Negotiating Team for Accession of Montenegro to the European Union Working Group for Chapter 18 – Statistics Bilateral screening: Chapter.
Mainstreaming horizontal principle Prevention of discrimination based on disability and accessibility
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
HIGHLIGHTS OF GENDER EQUALITY ACTIVITIES IN 2013 AND PRIORITIES IN 2014 PowerPoint presentation by Betty Doornenbal Gender Equality Expert (GEE) of the.
European Radiation Protection K. SCHNUER 4th ISOE European Workshop on Occupational Exposure Management at Nuclear Power Plants Lyon 24 to 26 March 2004.
2013 China-CEEC Business Council – proposed role and structure Michal Polański, Ph.D. Polish Agency for Enterprise Development Katowice, April 20th 2015.
EUNetPaS European Union Network for Patient Safety
For the EUROCHIP-3 project
Inese Vilcane Social inclusion department Senior expert
PRESENTATION OF MONTENEGRO
Corporate Restructuring And Workers' involvement
EU Reference Centres for Animal Welfare
The role of the EUMC and EU policies
ESF Transnational Cooperation.
SOCIAL DIALOGUE WITHIN EUPAN
Directors of Social Statistics
Task Force - Future of SD
National Cancer Center
Commission Activities Eurostat : Latest developments
SOCIAL DIALOGUE WITHIN THE SCOPE OF EUPAN
Task Force on Cervical Cancer Screening in Estonia
Meeting of the European Directors of Social Statistics
European Statistical System Network on Culture (ESSnet Culture)
5.b3 Monitoring & Reporting 2019
Cases of and deaths from cervical cancer, with associated incidence and mortality (rates per women), among Canadian women (2002–2006) by age group.
Presentation transcript:

DISCUSSIONS and DECISIONS Sophia, 22 nd May 2006 Public Health Program EUROPEAN COMMISSION: HEALTH & CONSUMER PROTECTION DIRECTORATE - GENERAL

BULGARIA: STATE OF THE ART Is organised screening present in the past? YES (up to 1989) Does this program have problems? YES (mortality did not decrease) Is organised screening present at the moment? NO At the moment are we in the position to reorganize the screening program? NO What is mainly necessary at the beginning? Which is the major problem at the moment? a. Political interest Steps to follow: a. MAJOR PROBLEM: To find groups of pressure (Groups like EuropaDonna, Medical Associations…) within the country and at international level b. To find practical proposals necessary to start the reorganization and also to solve problems in the past c. To start with Pilot Program: define the team that could promote and organize the Pilot

ROMANIA: STATE OF THE ART Is organised screening present in the past? NO Is organised screening present at the moment? NO At the moment are we in the position to organize a screening program? NO What is mainly necessary at the beginning? a. Practical proposal considering resources Steps to follow: a. Definition of the program in relation of the resources - Ex. Start at age 30 - Ex. Nurses are less expensive than GP b. Monitor the activity of cytologists c. To use correct indicators

LATVIA: STATE OF THE ART Is organised screening present in the past? NO Is organised screening present at the moment? Announced program (for GP), but none activity At the moment are we in the position to organize a screening program? NO What is mainly necessary at the beginning? Which is the major problem at the moment? a. Reorganization of the system (for pap-smear women prefer to go the gynecologist instead of GP) Steps to follow: a. To define the actors and improve the collaboration between figures involved in the program b. Education: reference with other countries c. To reconstruct the history of a sample of cervical cancer cases. It could be useful to understand which are priorities

LITHUANIA: STATE OF THE ART Is organised screening present in the past? NO Is organised screening present at the moment? YES Which is the major problem at the moment? a. Invitation system is in the hand of GPs. Women are invited if they go to GP Steps to follow: a. Centralisation of the invitation system for a pilot area

ESTONIA: STATE OF THE ART Is organised screening present in the past? NO Is organised screening present at the moment? YES Which are the major problems at the moment? a. Participation b. Non invitation of women without insurance c. Screening registry does not exist

TASK FORCE ACTIVITIES (1) 1.Groups of pressures. Ex: ONDA => European Parliament Meeting with women of the European Parliament (to organize probably in September 2006) Public opinion. Articles on newspapers and women magazines with a local vision 2.Information for local medical associations. EUROCHIP WT Task: Prepare a letter to send to local medical associations 3.Specific recommendations to Health Authorities at national level and at international level. EUROCHIP WT Task: paper for Network of Health Authorities. In the PAPER we will also invite the Health Ministries to inform the EC about the cervical cancer screening programs activated (info on structure, organization, results) WT: Working Team

4.Participation in the chapter on cancer in the EC Health Book 5.Meeting devoted to the discussion of technical aspects Probably period: before the end of Main tasks: Is our work compatible with European guidelines? Study of the possibility to develop a centralized information system (invitation, recall, monitor) in each country 6.To Share information. All information, all presentations will be available at the web-site 7.To change information with EUNICE in order to have standardize collection of data from new screening programs (it is really important to know the activities of the other European projects on this matter in order to avoid duplications) TASK FORCE ACTIVITIES (2) WT: Working Team